Indeed, the inhibition of neuroinflammation in mouse models can rescue many AD hallmarks, one of them being the LTP deficits in APP/PS1tg mice (Heneka et al., 2013; Lonnemann et al., 2020). This evidence concerns the gene APP and Alzheimer disease.